Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background Half-unit pens offer the ability to dose insulin more precisely. Information about half-unit pen use and evidence of their benefits and drawbacks is limited. This study aims to characterize people with type 1 diabetes (T1D) who have used (current/former = EVER) vs. those who have never used half-unit pens (NEVER users) and to understand their perspective.Methods An observational cross-sectional online survey was administered through T1D Exchange’s online patient community, myGlu.org, to understand the use of half-unit insulin pens.Results The 278 adult participants (156 EVER, 122 NEVER) had a mean age of 41.8 ± 12.7 years, body mass index of 26.0 ± 3.8 kg/m2, glycated hemoglobin of 6.3% ± 1.0%, and 55% were male. EVER users had T1D for a shorter duration than NEVER users (p < .001). EVER users were less likely to use continuous subcutaneous insulin infusion (p < .001) and more likely to start correcting high blood glucose at a lower level (p < .001) and low blood glucose at a higher level (p < .001). The highest ranked benefits of half-unit pen reported by its current users (N = 131) included prevention of hyperglycemia (40.5%), less anxiety or worry (23.7%), and prevention of hypoglycemia (16.8%).Conclusions Half-unit insulin pen is perceived as an insulin device that may help people with T1D to avoid hypo- and hyperglycemic events and decrease their level of disease worry and anxiety. This study highlights the need for patients and health care providers to understand the benefits of half-unit pens while considering options for individualized diabetes management.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Injecting insulin with a syringe or pen (136-147) is the insulin delivery method used by most people with diabetes (142,148), although inhaled insulin is also available.”
From 7. Diabetes Technology: Standards of Care in Diabetes—2025 (2025) · cites this paper as [136]
Citations
Cites
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Lee, W. C., Balu, S., Cobden, D., Joshi, A. V., & Pashos, C. L. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.004 · Cited by 266
Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.
Lteif, A. N., & Schwenk, W. F. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.137 · Cited by 146
Aleppo, G., Laffel, L. M., Ahmann, A. J., Hirsch, I. B., Kruger, D. F., Peters, A., Weinstock, R. S., & Harris, D. R. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00388 · Cited by 123
Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults
Kudva, Y. C., Ahmann, A. J., Bergenstal, R. M., Gavin, J. R., Kruger, D. F., Midyett, L. K., Miller, E., & Harris, D. R. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00294 · Cited by 97
Chandran, A., Bonafede, M. K., Nigam, S., Saltiel-Berzin, R., Hirsch, L. J., & Lahue, B. J. (2015) · PubMed · Cited by 62
Diabetes care - insulin delivery in a changing world.
Marcus, A. O. (2008) · PubMed · Cited by 39
Schade, D. S., & Valentine, V. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2100 · Cited by 37
Lee, I., Liu, H., Liau, Y., Lee, W., Huang, C., & Sheu, W. H. (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01086.x · Cited by 35
Research works printed but not linked: 5
- Baruah MP., 2011, J Assoc Physicians India, 59, 38
- Marcus A., 2008, Medscape J Med, 10, 120
- 2019, Diabetes Care, 42, S139
- Piscopo MA, 2003, Acta Bio-Medica: Atenei Parmensis, 74, 21
- Chandran A, 2015, Am Health Drug Benefits, 8, 148
Cited by
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
Yu, X., Yang, Z., Sun, X., Liu, H., Li, H., Lu, J., Zhou, J. H., & Çınar, A. (2025) · AI · doi:10.3390/ai6050087 · Cited by 31
Metadata
- Authors
- Piras de Oliveira, C., Mitchell, B. D., Fan, L., Garey, C., Liao, B., Bispham, J., Vint, N., Perez-Nieves, M., Hughes, A., & McAuliffe-Fogarty, A.
- Affiliations
- Eli Lilly and Company, Indianapolis, IN, USA
- Eli Lilly (United States) (US)
- T1D Exchange (US)
- T1D Exchange, Boston, MA, USA
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa UK Limited
- Published
- 2020-11-16
- Volume
- 37
- Issue
- 1
- Pages
- 45-51
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W3094678772
- Cited by
- 9
- References
- 19
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Current Medical Research and Opinion (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, patient perspectives, hypoglycemia prevention, hyperglycemia prevention, insulin pump therapy
- MeSH terms
- Adult, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemic Agents, Insulin, Male, Middle Aged, Patient Acceptance of Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study. https://app.cochat.ai/papers/10.1080/03007995.2020.1843423
- The paper
- Piras de Oliveira, C., Mitchell, B. D., Fan, L., Garey, C., Liao, B., Bispham, J., Vint, N., Perez-Nieves, M., Hughes, A., & McAuliffe-Fogarty, A. (2021). Patient perspectives on the use of half-unit insulin pens by people with type 1 diabetes: a cross-sectional observational study. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2020.1843423
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.